FierceBiotech 12 mar 2026 Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
Agilent 9 mar 2026 Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip - Investing.com
Endpoints News 6 mar 2026 Pfizer gets obesity drug approval in China shortly after buying local rights
FierceBiotech 4 mar 2026 Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations
FierceBiotech 25 feb 2026 After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
Endpoints News 24 feb 2026 Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News 7 feb 2026 The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
FierceBiotech 6 feb 2026 Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
BioPharma Dive 4 feb 2026 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
FierceBiotech 4 feb 2026 Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech 3 feb 2026 Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges